We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA’s Anesthetic and Analgesic Drug Products Advisory Committee split yesterday in a 6-6 vote over Durect’s Posirim (bupivacaine extended-release solution) for post-surgical analgesia. Read More
Opioid distribution data recently released by the Drug Enforcement Agency (DEA) shows an additional 24 billion opioid pills were distributed in the U.S. between 2013 and 2014 than was previously known. Read More
The Senate voted 89-10 yesterday to pass the United States-Mexico-Canada trade agreement, sending it to the president’s desk as generic and biologic drug advocates cheered the removal of a 10-year biologic exclusivity provision. Read More
In observance of Martin Luther King Jr. Day, Drug Industry Daily will not be published Monday, Jan. 20. The next issue will be published Tuesday, Jan. 21. Read More
The FDA released a draft guidance for oncology drug developers on submitting initial pediatric study plans (iPSPs) after new requirements go into effect on August 18. Read More
Rochester Drug Co-operative, one of the country’s top ten drug distributors, is pulling the plug on its opioid distribution operations after running into serious legal and regulatory troubles. Read More